Nuvation Bio Banner Image

Nuvation Bio

  • Ticker NUVB
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Nuvation Bio Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was foundedMore in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
4.0 / 5.0 (1)

Nuvation Bio reports have an aggregate usefulness score of 4.0 based on 1 reviews.

Nuvation Bio

Most Recent Annual Report

Nuvation Bio
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Nuvation Bio Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!